Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
This map shows the geographic impact of Murphy Sb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murphy Sb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murphy Sb more than expected).
This network shows the impact of papers produced by Murphy Sb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murphy Sb. The network helps show where Murphy Sb may publish in the future.
Co-authorship network of co-authors of Murphy Sb
This figure shows the co-authorship network connecting the top 25 collaborators of Murphy Sb.
A scholar is included among the top collaborators of Murphy Sb based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Murphy Sb. Murphy Sb is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
10 of 10 papers shown
1.
Martínez-Climent, José A., CM Rubin, Elaine Morgan, et al.. (1995). Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo.. PubMed. 9(1). 95–101.87 indexed citations
2.
Ch, Pui, et al.. (1992). Phase I study of recombinant human interferon gamma in children with relapsed acute leukemia.. PubMed. 6(11). 1181–4.15 indexed citations
3.
Mirro, J, et al.. (1986). Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.. PubMed. 70(3). 363–7.8 indexed citations
4.
Sb, Murphy, et al.. (1985). Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983).. PubMed. 405–18.4 indexed citations
Sb, Murphy. (1977). Prognostic features and obstacles to cure of childhood non-Hodgkin's lymphoma.. PubMed. 4(3). 265–71.46 indexed citations
9.
Sb, Murphy, et al.. (1976). Evidence for recruitment and synchronization in leukemia and solid tumors.. PubMed. 60(12). 1841–4.1 indexed citations
10.
Sb, Murphy, et al.. (1974). Hodgkin's disease and the non-Hodgkin's lymphomas in childhood.. PubMed. 1(1). 17–26.6 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.